Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 3 studies | 32% ± 2% |
Insufficient scRNA-seq data for expression of ANKRD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 87% | 332.87 | 77 / 89 | 55% | 13.79 | 500 / 901 |
brain | 73% | 92.95 | 1935 / 2642 | 35% | 0.90 | 248 / 705 |
muscle | 100% | 32638.46 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 9334.08 | 860 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 53% | 41.62 | 138 / 258 | 31% | 2.26 | 71 / 230 |
skin | 72% | 101.45 | 1297 / 1809 | 5% | 0.30 | 25 / 472 |
lung | 41% | 49.77 | 236 / 578 | 35% | 1.31 | 399 / 1155 |
ovary | 4% | 3.00 | 8 / 180 | 62% | 3.83 | 268 / 430 |
esophagus | 24% | 60.27 | 351 / 1445 | 28% | 0.65 | 51 / 183 |
blood vessel | 52% | 92.92 | 692 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 1.50 | 14 / 29 |
pancreas | 7% | 5.02 | 22 / 328 | 41% | 0.87 | 73 / 178 |
uterus | 5% | 5.84 | 9 / 170 | 41% | 1.78 | 187 / 459 |
prostate | 24% | 190.38 | 60 / 245 | 12% | 1.69 | 60 / 502 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.48 | 16 / 45 |
breast | 15% | 22.86 | 71 / 459 | 16% | 0.43 | 181 / 1118 |
bladder | 0% | 0 | 0 / 21 | 27% | 1.11 | 137 / 504 |
liver | 4% | 4.00 | 8 / 226 | 19% | 1.31 | 78 / 406 |
peripheral blood | 17% | 45.33 | 159 / 929 | 0% | 0 | 0 / 0 |
thymus | 6% | 22.84 | 41 / 653 | 8% | 0.31 | 51 / 605 |
adipose | 10% | 11.51 | 121 / 1204 | 0% | 0 | 0 / 0 |
intestine | 6% | 4.57 | 61 / 966 | 4% | 0.13 | 19 / 527 |
stomach | 4% | 2.71 | 15 / 359 | 5% | 0.14 | 15 / 286 |
eye | 0% | 0 | 0 / 0 | 6% | 0.19 | 5 / 80 |
spleen | 4% | 3.49 | 10 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0006936 | Biological process | muscle contraction |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007517 | Biological process | muscle organ development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016605 | Cellular component | PML body |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000791 | Cellular component | euchromatin |
GO_0031674 | Cellular component | I band |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0043422 | Molecular function | protein kinase B binding |
GO_0005515 | Molecular function | protein binding |
GO_0008307 | Molecular function | structural constituent of muscle |
Gene name | ANKRD2 |
Protein name | Ankyrin repeat domain 2 Ankyrin repeat domain-containing protein 2 (Skeletal muscle ankyrin repeat protein) (hArpp) |
Synonyms | ARPP |
Description | FUNCTION: Functions as a negative regulator of myocyte differentiation. May interact with both sarcoplasmic structural proteins and nuclear proteins to regulate gene expression during muscle development and in response to muscle stress. . |
Accessions | ENST00000298808.9 [Q9GZV1-2] Q5T457 ENST00000455090.1 ENST00000370655.6 Q9GZV1 A0A0A0MRN9 ENST00000307518.9 [Q9GZV1-1] |